Nathan R. Miselis
SQZ Biotech (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Virus-based gene therapy research, DNA Repair Mechanisms, Cancer-related Molecular Pathways, CAR-T cell therapy research
Most-Cited Works
- → Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?(2009)176 cited
- → Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors(2018)146 cited
- → Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma(2008)106 cited
- → Homologous and Nonhomologous Recombination Resulting in Deletion: Effects of p53 Status, Microhomology, and Repetitive DNA Length and Orientation(2000)98 cited
- → Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition(2012)82 cited
- → Efficient Repair of All Types of Single-Base Mismatches in Recombination Intermediates in Chinese Hamster Ovary Cells: Competition Between Long-Patch and G-T Glycosylase-Mediated Repair of G-T Mismatches(1998)58 cited
- → MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis(2014)53 cited
- → A role for p53 in DNA end rejoining by human cell extracts(1997)47 cited
- → Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma(2010)14 cited
- → Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors(2023)6 cited